Emergence of carbapenem resistant gram-negative pathogens with high rate of colistin resistance in Egypt: A cross sectional study to assess resistance trends during the COVID-19 pandemic

Emergence of carbapenem resistant gram-negative pathogens with high rate of colistin resistance in Egypt: A cross sectional study to assess resistance trends during the COVID-19 pandemic

The current study investigated the temporal phenotypic and genotypic antimicrobial resistance (AMR) trends among multi-drug resistant and carbapenem-resistant Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa recovered from Egyptian clinical settings between 2020 and 2021. B...

Full description

Bibliographic Details
Main Authors:	Fatma A. Afify, Ahmed H. Shata, Nirmeen Aboelnaga, Dina Osama, Salma W. Elsayed, Nehal A. Saif, Shaimaa F. Mouftah, Sherine M. Shawky, Ahmed A. Mohamed, Omar Loay, Mohamed Elhadidy
Format:	Article
Language:	English
Published:	SpringerOpen 2024-03-01
Series:	Journal of Genetic Engineering and Biotechnology
Subjects:	Gram negative bacteria Multidrug resistance Colistin resistance Carbapenem resistance Class 1 integron
Online Access:	http://www.sciencedirect.com/science/article/pii/S1687157X2300001X

Similar Items

Effectiveness of Colistin in carbapenem resistant Acinetobacter baumannii – A systematic review
by: Feroz Ahmed, et al.
Published: (2023-09-01)

Colistin and carbapenem resistance among Pseudomonas and Acinetobacter clinical isolates in Menoufia University Hospitals
by: Amal Makled, et al.
Published: (2024-02-01)

Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
by: Po-Han Huang, et al.
Published: (2022-06-01)

Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit
by: Ilhaam Abrahams, et al.
Published: (2023-01-01)

Molecular epidemiology and mechanisms of carbapenem and colistin resistance in Klebsiella and other Enterobacterales from treated wastewater in Croatia
by: Ana Puljko, et al.
Published: (2024-03-01)

Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe
by: Ivana Goic-Barisic, et al.
Published: (2023-06-01)

Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant Enterobacteriaceae
by: Hadir A. El-Mahallawy, et al.
Published: (2022-12-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

Emergence of colistin-heteroresistant and carbapenem-resistant hypervirulent Klebsiella pneumoniae
by: Tao Wang, et al.
Published: (2023-12-01)

Occurrence of Extended Spectrum Cephalosporin-, Carbapenem- and Colistin-Resistant Gram-Negative Bacteria in Fresh Vegetables, an Increasing Human Health Concern in Algeria
by: Widad Chelaghma, et al.
Published: (2022-07-01)

Colistin-resistance gene mcr in clinical carbapenem-resistant Enterobacteriaceae strains in China, 2014–2019
by: Hong Huang, et al.
Published: (2020-01-01)

Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii
by: Hadas Kon, et al.
Published: (2023-06-01)

Pairing Colicins B and E5 with Bdellovibrio bacteriovorus To Eradicate Carbapenem- and Colistin-Resistant Strains of Escherichia coli
by: Sumudu Upatissa, et al.
Published: (2023-06-01)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022-11-01)

Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases
by: Yuanbing Wu, et al.
Published: (2024-01-01)

Carbapenem- and colistin-resistant Enterobacterales in intensive care unit patients in Mediterranean countries, 2019
by: Sandra Dos Santos, et al.
Published: (2024-04-01)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021-08-01)

Assessing Colistin Resistance by Phenotypic and Molecular Methods in Carbapenem-resistant Enterobacterales in a Tertiary Care Hospital in Pakistan
by: Furqan W, et al.
Published: (2022-10-01)

Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study
by: Sheng-Huei Wang, et al.
Published: (2021-09-01)

Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
by: Shrief R, et al.
Published: (2022-10-01)

Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study
by: Davide Fiore Bavaro, et al.
Published: (2023-09-01)

Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil?
by: Flavia Rossi, et al.

Molecular Characteristics and Quantitative Proteomic Analysis of <i>Klebsiella pneumoniae</i> Strains with Carbapenem and Colistin Resistance
by: Ling Hao, et al.
Published: (2022-09-01)

Molecular Epidemiology of Extensively Drug-Resistant <i>mcr</i> Encoded Colistin-Resistant Bacterial Strains Co-Expressing Multifarious β-Lactamases
by: Hasan Ejaz, et al.
Published: (2021-04-01)

Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant <i>Klebsiella pneumoniae</i>
by: Tsung-Ying Yang, et al.
Published: (2021-08-01)

Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19
by: Samaneh Pourajam, et al.
Published: (2023-03-01)

Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection
by: Zihao Zheng, et al.
Published: (2023-10-01)

Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis
by: Wasan Katip, et al.
Published: (2024-05-01)

A Clinico-Microbiological Study of Blood Stream Infections in a Tertiary Referral Hospital: Colistin Resistance & Challenges
by: Samandeep Kaur, et al.
Published: (2023-03-01)

Multicenter Study of Colistin Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae Strains in China
by: Yuesong Weng, et al.
Published: (2023-08-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

The Effect of Aminoglycosides on Colistin-Containing Regimens in the Treatment of Carbapenem-Resistant Gram-Negative Infections in Pediatric Intensive Care Units: A Two-Center Experience
by: Zümrüt Şahbudak Bal, et al.
Published: (2019-09-01)

Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli
by: Min Hao, et al.
Published: (2022-10-01)

Investigation of Colistin Heteroresistance and Some Factors Affecting Heteroresistance in Carbapenem-Resistant A. baumannii Strains
by: Deniz GAZEL, et al.
Published: (2017-12-01)

Outbreak of colistin and carbapenem-resistant Klebsiella pneumoniae ST16 co-producing NDM-1 and OXA-48 isolates in an Iranian hospital
by: Rahimeh Sanikhani, et al.
Published: (2024-02-01)

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant <i>Acinetobacter baumannii</i> Using the Broth Microdilution Checkerboard and Time-Kill Methods
by: Vipavee Rodjun, et al.
Published: (2020-08-01)

Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates
by: Saranya Vijayakumar, et al.
Published: (2024-02-01)

Hospital-acquired infections due to carbapenem-resistant Providencia stuartii
by: Swati Sharma, et al.
Published: (2023-01-01)

Carbapenem-Resistant Enterobacteria: How to Cope?
by: Füsun Zeynep Akçam
Published: (2019-06-01)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2020-09-01)